New CEO heads Symphony's quartet

Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.

He is orchestrating the four companies of which Symphony is composed: Source Healthcare Analytics, ImpactRx, TargetRx and AlphaDetail.

Symphony was formed by parent Symphony Technology Group last May after the private equity firm acquired the Source business from Wolters Kluwer for an undisclosed sum.

After the sale, Source's co-presidents Bob Jansen and Michelle Woker stayed on. A month later, Symphony Health announced that it had appointed an IMS Health and Thomson Healthcare veteran as its new CEO, but apparently the appointment didn't work out.

For the past four years, Lavelle led the educational division of SunGard Data Systems. Before that, he served as CEO for Siemens Medical Solutions and president for Medquist.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.